United States Biotechnology & Medical Research

ARS Pharmaceuticals, Inc. (SPRY)

Track

Track

ARS Pharmaceuticals experienced significant insider trading activity recently, with executives offloading over $3.2 million in shares. These sales occurred following a disappointing earnings report. The stock price has declined nearly 50% over the last quarter, reflecting downward pressure as leadership reduced their equity positions amid ongoing market volatility.
Ticker: SPRY Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ARS Pharmaceuticals, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
112.39
Quantity 22,581
Value US$2,008,751
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
94.69
Quantity 62,482
Value US$2,485,923
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
421.89
Quantity 22,176
Value US$2,293,979
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
4.96
Quantity 14,064
Value US$69,762
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.61
Quantity 75,000
Value US$421,058
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.84
Quantity 19,805
Value US$115,564
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.95
Quantity 840
Value US$5,000
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.01
Quantity 45,388
Value US$272,850
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
5.82
Quantity 63,289
Value US$368,099
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
5.92
Quantity 25,000
Value US$147,970
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
5.93
Quantity 25,000
Value US$148,160
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.45
Quantity 25,000
Value US$161,170
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
6.45
Quantity 50,000
Value US$322,345
SARINA TANIMOTO Officer; 10% Stockholder Officer Large shareholder
Transaction date
Proposed sale
Price
6.30
Quantity 49,401
Value US$311,192
RICHARD LOWENTHAL Officer; Director; 10% Stockholder Executive Director Large shareholder
Transaction date
Proposed sale
Price
6.32
Quantity 50,000
Value US$315,885
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 25,000 -67.2%
Value US$250,000
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Planned sale
Price
10.00
Quantity 3,355 -3.6%
Value US$33,550
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
10.00
Quantity 25,000
Value US$250,000
3.3
ALEXANDER FITZPATRICK Officer Officer
Transaction date
Proposed sale
Price
10.00
Quantity 3,355
Value US$33,550
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
8.71
Quantity 21,828 -66.9%
Value US$190,050
1.9
BRIAN T DORSEY Officer Officer
Transaction date
Proposed sale
Price
8.71
Quantity 21,828
Value US$190,050
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.86
Quantity 136,380 -100.0%
Value US$1,208,790
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
8.91
Quantity 30,000 -18.0%
Value US$267,357
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
9.00
Quantity 136,380
Value US$1,227,420
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
8.87
Quantity 138,380
Value US$1,227,420
3.2
JUSTIN CHAKMA Officer Officer
Transaction date
Proposed sale
Price
8.91
Quantity 30,000
Value US$267,357
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
14.49
Quantity 50,000 -4.0%
Value US$724,345
3.0
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 12,500 -55.5%
Value US$187,500
3.0
KATHLEEN D SCOTT Officer Officer
Transaction date
Proposed sale
Price
15.00
Quantity 12,500
Value US$187,500
Lowenthal Richard E Officer; Director; Member of immediate family of any of the foregoing Executive Director
Transaction date
Proposed sale
Price
14.15
Quantity 150,000
Value US$2,123,000
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.09
Quantity 37,656 -2.9%
Value US$530,626
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
14.03
Quantity 12,344 -1.0%
Value US$173,130
Tanimoto Sarina Officer; Member of immediate family of any of the foregoing Officer
Transaction date
Proposed sale
Price
14.00
Quantity 150,000
Value US$2,100,000
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.99
Quantity 15,000 -59.3%
Value US$254,860
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.99
Quantity 15,000
Value US$254,859
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,074 -7.0%
Value US$6,831,566
2.8
Flynn James E Large shareholder
Transaction date
Sale
Price
18.46
Quantity 370,075 -7.0%
Value US$6,831,584
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
16.00
Quantity 15,000 -66.1%
Value US$240,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
16.00
Quantity 15,000
Value US$240,000
3.1
SAUNDERS BRENT L Non-Executive Director
Transaction date
Sale
Price
14.25
Quantity 120,000 -100.0%
Value US$1,710,024
3.0
Scott Kathleen D. Chief Financial Officer Officer
Transaction date
Sale
Price
14.10
Quantity 50,000 -87.1%
Value US$705,165
3.3
Fitzpatrick Alexander A Chief Legal Officer Officer
Transaction date
Sale
Price
14.10
Quantity 102,969 -53.5%
Value US$1,451,513
3.0
Scott Kathleen D. Officer Officer
Transaction date
Proposed sale
Price
14.10
Quantity 50,000
Value US$705,000
3.3
Fitzpatrick Alexander A Officer Officer
Transaction date
Proposed sale
Price
14.02
Quantity 102,969
Value US$1,443,894
3.1
SAUNDERS BRENT L Director Non-Executive Director
Transaction date
Proposed sale
Price
14.25
Quantity 120,000
Value US$1,710,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.30
Quantity 50,002 -19.2%
Value US$615,075
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.30
Quantity 50,002
Value US$615,051
Karas Eric Chief Commercial Officer Officer
Transaction date
Planned sale
Price
14.00
Quantity 10,000 -56.5%
Value US$140,000
ERIC KARAS Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 10,000
Value US$140,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.21
Quantity 49,600 -19.1%
Value US$556,046
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.00
Quantity 400 -0.2%
Value US$4,400
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.00
Quantity 50,000
Value US$550,000
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
12.31
Quantity 50,000 -19.2%
Value US$615,565
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
12.31
Quantity 50,000
Value US$615,565
0.5
Shawver Laura Non-Executive Director
Transaction date
Planned sale
Price
11.10
Quantity 50,000 -19.2%
Value US$555,065
0.5
Shawver Laura Director Non-Executive Director
Transaction date
Proposed sale
Price
11.10
Quantity 50,000
Value US$555,065
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -4.4%
Value US$583,525
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
11.67
Quantity 50,000 -3.7%
Value US$583,575
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
12.06
Quantity 27,272
Value US$328,967
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.06
Quantity 27,272 -16.7%
Value US$328,968
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Sale
Price
12.30
Quantity 25,000 -80.6%
Value US$307,432
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
12.27
Quantity 117,333 -46.2%
Value US$1,439,124
1.9
Dorsey Brian Chief Operating Officer Officer
Transaction date
Planned sale
Price
12.43
Quantity 15,000 -71.3%
Value US$186,426
1.9
Dorsey Brian Officer Officer
Transaction date
Proposed sale
Price
13.31
Quantity 61,200
Value US$814,572
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
11.50
Quantity 117,333
Value US$1,349,330
3.2
Chakma Justin Chief Business Officer Officer
Transaction date
Sale
Price
13.15
Quantity 50,000 -26.8%
Value US$657,625
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Tanimoto Sarina CHIEF MEDICAL OFFICER Officer Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.16
Quantity 50,000 -4.2%
Value US$658,155
Lowenthal Richard E PRESIDENT AND CEO Executive Director Large shareholder
Transaction date
Planned sale
Price
13.17
Quantity 50,000 -3.9%
Value US$658,265
3.2
Chakma Justin Director Non-Executive Director
Transaction date
Proposed sale
Price
14.02
Quantity 50,000
Value US$701,000
Lowenthal Richard E Officer; Director; Member of immediate family of any of the foregoing Executive Director
Transaction date
Proposed sale
Price
13.40
Quantity 300,000
Value US$4,020,000
3.2
Chakma Justin Officer Officer
Transaction date
Proposed sale
Price
14.00
Quantity 50,000
Value US$700,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-01 2026-10-01 PrS Proposed sale
ERIC KARAS

Officer

Officer
22,581
112.39
US$2,008,751 		22,581 112.39 US$2,008,751
2026-09-30 2026-09-30 PrS Proposed sale
ERIC KARAS

Officer

Officer
62,482
94.69
US$2,485,923 		62,482 94.69 US$2,485,923
2026-09-11 2026-09-11 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
22,176
421.89
US$2,293,979 		22,176 421.89 US$2,293,979
2026-09-11 2026-09-11 PrS Proposed sale
ERIC KARAS

Officer

Officer
14,064
4.96
US$69,762 		14,064 4.96 US$69,762
2026-09-04 2026-09-04 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
75,000
5.61
US$421,058 		75,000 5.61 US$421,058
2026-09-03 2026-09-03 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
19,805
5.84
US$115,564 		19,805 5.84 US$115,564
2026-09-02 2026-09-02 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
840
5.95
US$5,000 		840 5.95 US$5,000
2026-09-01 2026-09-01 PrS Proposed sale
SARINA TANIMOTO

Officer; 10% Stockholder

Officer Large shareholder
45,388
6.01
US$272,850 		45,388 6.01 US$272,850
2026-08-31 2026-08-31 PrS Proposed sale
SARINA TANIMOTO

Officer; 10% Stockholder

Officer Large shareholder
63,289
5.82
US$368,099 		63,289 5.82 US$368,099
2026-08-20 2026-08-20 PrS Proposed sale
SARINA TANIMOTO

Officer; 10% Stockholder

Officer Large shareholder
25,000
5.92
US$147,970 		25,000 5.92 US$147,970
2026-08-20 2026-08-20 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
25,000
5.93
US$148,160 		25,000 5.93 US$148,160
2026-08-19 2026-08-19 PrS Proposed sale
SARINA TANIMOTO

Officer; 10% Stockholder

Officer Large shareholder
25,000
6.45
US$161,170 		25,000 6.45 US$161,170
2026-08-19 2026-08-19 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
50,000
6.45
US$322,345 		50,000 6.45 US$322,345
2026-08-18 2026-08-18 PrS Proposed sale
SARINA TANIMOTO

Officer; 10% Stockholder

Officer Large shareholder
49,401
6.30
US$311,192 		49,401 6.30 US$311,192
2026-08-18 2026-08-18 PrS Proposed sale
RICHARD LOWENTHAL

Officer; Director; 10% Stockholder

Executive Director Large shareholder
50,000
6.32
US$315,885 		50,000 6.32 US$315,885
2026-06-12 2026-06-12 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
25,000 -67.2%
10.00
US$250,000 		25,000 -67.2% 10.00 US$250,000
2026-06-12 2026-06-12 PlS Planned sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
3,355 -3.6%
10.00
US$33,550 		3,355 -3.6% 10.00 US$33,550
2026-06-12 2026-06-12 PrS Proposed sale
ERIC KARAS

Officer

Officer
25,000
10.00
US$250,000 		25,000 10.00 US$250,000
2026-06-12 2026-06-12 PrS Proposed sale
3.3
ALEXANDER FITZPATRICK

Officer

Officer
3,355
10.00
US$33,550 		3,355 10.00 US$33,550
2025-11-14 2025-11-13 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
21,828 -66.9%
8.71
US$190,050 		21,828 -66.9% 8.71 US$190,050
2025-11-13 2025-11-13 PrS Proposed sale
1.9
BRIAN T DORSEY

Officer

Officer
21,828
8.71
US$190,050 		21,828 8.71 US$190,050
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
136,380 -100.0%
8.86
US$1,208,790 		136,380 -100.0% 8.86 US$1,208,790
2025-11-14 2025-11-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
30,000 -18.0%
8.91
US$267,357 		30,000 -18.0% 8.91 US$267,357
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
136,380
9.00
US$1,227,420 		136,380 9.00 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
138,380
8.87
US$1,227,420 		138,380 8.87 US$1,227,420
2025-11-12 2025-11-12 PrS Proposed sale
3.2
JUSTIN CHAKMA

Officer

Officer
30,000
8.91
US$267,357 		30,000 8.91 US$267,357
2025-08-22 2025-08-21 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.0%
14.49
US$724,345 		50,000 -4.0% 14.49 US$724,345
2025-08-22 2025-08-21 PlS Planned sale
3.0
Scott Kathleen D.

Chief Financial Officer

Officer
12,500 -55.5%
15.00
US$187,500 		12,500 -55.5% 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
3.0
KATHLEEN D SCOTT

Officer

Officer
12,500
15.00
US$187,500 		12,500 15.00 US$187,500
2025-08-21 2025-08-21 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
150,000
14.15
US$2,123,000 		150,000 14.15 US$2,123,000
2025-08-21 2025-08-20 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
37,656 -2.9%
14.09
US$530,626 		37,656 -2.9% 14.09 US$530,626
2025-08-21 2025-08-19 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
12,344 -1.0%
14.03
US$173,130 		12,344 -1.0% 14.03 US$173,130
2025-08-19 2025-08-19 PrS Proposed sale
Tanimoto Sarina

Officer; Member of immediate family of any of the foregoing

Officer
150,000
14.00
US$2,100,000 		150,000 14.00 US$2,100,000
2025-07-03 2025-07-01 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -59.3%
16.99
US$254,860 		15,000 -59.3% 16.99 US$254,860
2025-07-01 2025-07-01 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.99
US$254,859 		15,000 16.99 US$254,859
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,074 -7.0%
18.46
US$6,831,566 		370,074 -7.0% 18.46 US$6,831,566
2025-07-01 2025-06-27 S Sale
2.8
Flynn James E
Large shareholder
370,075 -7.0%
18.46
US$6,831,584 		370,075 -7.0% 18.46 US$6,831,584
2025-06-20 2025-06-18 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
15,000 -66.1%
16.00
US$240,000 		15,000 -66.1% 16.00 US$240,000
2025-06-18 2025-06-18 PrS Proposed sale
ERIC KARAS

Officer

Officer
15,000
16.00
US$240,000 		15,000 16.00 US$240,000
2025-05-22 2025-05-20 S Sale
3.1
SAUNDERS BRENT L
Non-Executive Director
120,000 -100.0%
14.25
US$1,710,024 		120,000 -100.0% 14.25 US$1,710,024
2025-05-22 2025-05-20 S Sale
3.0
Scott Kathleen D.

Chief Financial Officer

Officer
50,000 -87.1%
14.10
US$705,165 		50,000 -87.1% 14.10 US$705,165
2025-05-22 2025-05-20 S Sale
3.3
Fitzpatrick Alexander A

Chief Legal Officer

Officer
102,969 -53.5%
14.10
US$1,451,513 		102,969 -53.5% 14.10 US$1,451,513
2025-05-20 2025-05-20 PrS Proposed sale
3.0
Scott Kathleen D.

Officer

Officer
50,000
14.10
US$705,000 		50,000 14.10 US$705,000
2025-05-20 2025-05-20 PrS Proposed sale
3.3
Fitzpatrick Alexander A

Officer

Officer
102,969
14.02
US$1,443,894 		102,969 14.02 US$1,443,894
2025-05-20 2025-05-20 PrS Proposed sale
3.1
SAUNDERS BRENT L

Director

Non-Executive Director
120,000
14.25
US$1,710,000 		120,000 14.25 US$1,710,000
2025-04-08 2025-04-07 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,002 -19.2%
12.30
US$615,075 		50,002 -19.2% 12.30 US$615,075
2025-04-07 2025-04-07 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,002
12.30
US$615,051 		50,002 12.30 US$615,051
2025-03-21 2025-03-20 PlS Planned sale
Karas Eric

Chief Commercial Officer

Officer
10,000 -56.5%
14.00
US$140,000 		10,000 -56.5% 14.00 US$140,000
2025-03-20 2025-03-20 PrS Proposed sale
ERIC KARAS

Officer

Officer
10,000
14.00
US$140,000 		10,000 14.00 US$140,000
2025-03-07 2025-03-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
49,600 -19.1%
11.21
US$556,046 		49,600 -19.1% 11.21 US$556,046
2025-03-07 2025-03-05 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
400 -0.2%
11.00
US$4,400 		400 -0.2% 11.00 US$4,400
2025-03-05 2025-03-05 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.00
US$550,000 		50,000 11.00 US$550,000
2025-02-04 2025-02-03 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
12.31
US$615,565 		50,000 -19.2% 12.31 US$615,565
2025-02-03 2025-02-03 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
12.31
US$615,565 		50,000 12.31 US$615,565
2025-01-07 2025-01-06 PlS Planned sale
0.5
Shawver Laura
Non-Executive Director
50,000 -19.2%
11.10
US$555,065 		50,000 -19.2% 11.10 US$555,065
2025-01-06 2025-01-06 PrS Proposed sale
0.5
Shawver Laura

Director

Non-Executive Director
50,000
11.10
US$555,065 		50,000 11.10 US$555,065
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.4%
11.67
US$583,525 		50,000 -4.4% 11.67 US$583,525
2024-12-19 2024-12-17 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.7%
11.67
US$583,575 		50,000 -3.7% 11.67 US$583,575
2024-12-13 2024-12-13 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
27,272
12.06
US$328,967 		27,272 12.06 US$328,967
2024-12-13 2024-12-13 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
27,272 -16.7%
12.06
US$328,968 		27,272 -16.7% 12.06 US$328,968
2024-12-13 2024-12-12 S Sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
25,000 -80.6%
12.30
US$307,432 		25,000 -80.6% 12.30 US$307,432
2024-12-13 2024-12-12 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
117,333 -46.2%
12.27
US$1,439,124 		117,333 -46.2% 12.27 US$1,439,124
2024-12-13 2024-12-11 PlS Planned sale
1.9
Dorsey Brian

Chief Operating Officer

Officer
15,000 -71.3%
12.43
US$186,426 		15,000 -71.3% 12.43 US$186,426
2024-12-11 2024-12-11 PrS Proposed sale
1.9
Dorsey Brian

Officer

Officer
61,200
13.31
US$814,572 		61,200 13.31 US$814,572
2024-12-12 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
117,333
11.50
US$1,349,330 		117,333 11.50 US$1,349,330
2024-12-12 2024-12-10 S Sale
3.2
Chakma Justin

Chief Business Officer

Officer
50,000 -26.8%
13.15
US$657,625 		50,000 -26.8% 13.15 US$657,625
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Tanimoto Sarina

CHIEF MEDICAL OFFICER

Officer Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -4.2%
13.16
US$658,155 		50,000 -4.2% 13.16 US$658,155
2024-12-11 2024-12-10 PlS Planned sale
Lowenthal Richard E

PRESIDENT AND CEO

Executive Director Large shareholder
50,000 -3.9%
13.17
US$658,265 		50,000 -3.9% 13.17 US$658,265
2024-12-10 2024-12-10 PrS Proposed sale
3.2
Chakma Justin

Director

Non-Executive Director
50,000
14.02
US$701,000 		50,000 14.02 US$701,000
2024-12-10 2024-12-10 PrS Proposed sale
Lowenthal Richard E

Officer; Director; Member of immediate family of any of the foregoing

Executive Director
300,000
13.40
US$4,020,000 		300,000 13.40 US$4,020,000
2024-12-06 2024-12-06 PrS Proposed sale
3.2
Chakma Justin

Officer

Officer
50,000
14.00
US$700,000 		50,000 14.00 US$700,000
Explore more

More insider trading research around ARS Pharmaceuticals, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America